Global Veterinary Vaccines Market Overview
Veterinary Vaccines are adopted to provide active acquired immunity against a range of diseases such as, foot & mouth diseases, rabies, and equine influenza virus. Wherein the vaccines against these diseases mimic the naturally acquired immunity to prevent the transmission of infectious agents. Growing dairy and poultry industry around the globe and increasing outbreaks of zoonotic diseases is anticipated to drive the market steadily during the forecast period. Increasing urbanization has led to the presence of wild animals living in close proximity to humans which increases the transmission rate of infections, serving as a factor in the growth of veterinary vaccines market over the forecast period.
Market Size & Forecast
Veterinary Vaccines Market is anticipated to record a significant CAGR of 5.7% over the forecast period. Growing government initiatives to limit the spread of zoonotic diseases across the under-developed as well as developing regions around the globe on the back of increasing number of human infections due to animal diseases such as, rabies, foot & mouth diseases, and equine influenza are expected to propel the veterinary vaccines market over the forecast period. Significant rise in the rate of pet ownerships around the globe has considerably aided in the steady growth of veterinary vaccines market further. Increasing R&D investments by regional as well as global organizations in order to cease poultry disease spread by discovery on newer vaccines is expected to display a stable growth of veterinary vaccines market over the forecast period.
On the basis of regional platform, global Veterinary Vaccines market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
North America is panned to observe substantial veterinary vaccines market growth on the back of growing number of pet ownerships across the region along with rising number of pet health concerned owners. North America is anticipated to be followed by Asia Pacific in terms of consumption due to increasing outbreaks of animal infected or zoonotic diseases across the region over the past and is estimated to rise further during the forecast period.
Europe is expected to drive demand and positively impact veterinary vaccines market growth over the forecast period owing to being a dairy and poultry dependent food region. Increasing initiatives by regulatory bodies and growing concerns regarding food safety among the population, is attributed to propel the veterinary vaccines market substantially across the region.
Growth Drivers & Challenges
On the back of Increasing Diseases Prevalence in Livestock
Rising incidences of zoonotic diseases along with increasing reports of livestock diseases across the globe is anticipated to propel the veterinary vaccines market considerably over the forecast period. The global Food and Agriculture Organization reported an increase in the total number of livestock animal heads from 5.90 million heads in 2010 to 6.33 million heads in 2016 on the back of growing pressure on food chain with increasing global population. This increase in number of livestock is expected to result in increased demand for livestock vaccines, leading in positively impacting the veterinary vaccines market during the forecast period. Additionally, increasing incidences of livestock diseases such as, Q fever, anthrax, foot and mouth disease and others are expected to drive the veterinary vaccines market considerably across the globe.
Increasing Expenditure on Pet Healthcare
On account of increasing adoption of pets around the world as well as growing number of veterinary diseases is attributed to exhibit a positive growth of veterinary vaccines market during the forecast period. On the back of increasing incidences of avian influenza transmissible from animal to human, the veterinary vaccines market is anticipated to perceive a substantial growth across the globe. The World Health Organization reports that avian influenza subtypes A (H5N1), A (H7N9), and A (H9N2) exist around the globe that can be acquired by humans through direct contact with infected animals. Additionally, increasing adoption of swine as pet animals and frequent outbreaks of swine flu is expected to drive the veterinary vaccines market further during the forecast period.
Moreover, rising number of rotavirus and rift valley fever along with increasing animal vaccination programs is projected to aid the veterinary vaccines market rapidly over the forecast period.
Rising number of Cold Storage Chains
However, developing chains of cold storage systems across under-developed and developing nations along with pertaining side effects of vaccination restrain the sturdy growth of veterinary vaccines during the forecast period. Furthermore, consolidation among the distributors is bulldozing the veterinary vaccines market with already crunched margins which is estimated to serve further as a limit to the growth of veterinary vaccines market during the forecast period.
Market Segmentation
Our-in depth analysis of the global Veterinary Vaccines market includes the following segments:
By Technology
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Other Technologies
By Vaccine Type
- Livestock Vaccines
- Bovine Vaccines
- Poultry Vaccines
- Porcine Vaccines
- Other Livestock Vaccines
- Companion Animal Vaccines
- Canine Vaccines
- Feline Vaccines
- Equine Vaccines
By Route of Administration
- Oral
- Parental
- Topical
Get more information on this report: Download Sample PDF
By Region
Global Veterinary Vaccines Market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Top Featured Companies Dominating The Market
- Merck & Co.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Zoetis Animal Healthcare
- Virbac
- Hester Biosciences Ltd
- Eli Lilly & Company
- Boehringer Ingelheim Animal Health GmbH
- Ceva Sante Animale
- Phibro Animal Health Corp.
- HIPRA
- Bayer Animal Health
- Other Prominent Players
